Question 1

What are the potential benefits of combining ipilimumab with dasatinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia clinical trial (NCT00732186). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I be aware of with this combination therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia clinical trial (NCT00732186). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my response to treatment be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia clinical trial (NCT00732186). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia clinical trial (NCT00732186). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there other treatment options available if I don't qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia clinical trial (NCT00732186). Contact the study team or your healthcare provider for specific answers.

Question 6

How often will I need to visit the clinic for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia clinical trial (NCT00732186). Contact the study team or your healthcare provider for specific answers.

What this study is about